Health Catalyst, Inc Common Stock
HCAT Real Time Price USDRecent trades of HCAT by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by HCAT's directors and management
Government lobbying spending instances
-
$60,000 Jan 19, 2023 Issue: Veterans Health Issues
-
$60,000 Oct 20, 2022 Issue: Veterans Health Issues
-
$60,000 Jul 20, 2022 Issue: Health Issues
-
$60,000 Apr 18, 2022 Issue: Health Issues
-
$60,000 Jan 20, 2022 Issue: Health Issues
-
$60,000 Oct 20, 2021 Issue: Health Issues
-
$60,000 Jul 20, 2021 Issue: Health Issues
-
$60,000 Apr 20, 2021 Issue: Health Issues
-
$60,000 Jan 21, 2021 Issue: Health Issues
-
$60,000 Oct 20, 2020 Issue: Health Issues
-
$30,000 Jul 20, 2020 Issue: Health Issues
Estimated quarterly lobbying spending
HCAT Revenue by Segment or Geography
No Revenue by Segment data for this ticker
No Revenue by Geography data for this ticker
New patents grants
-
Patent Title: Minimize garbage collection in hl7 manipulation Oct. 31, 2023
-
Patent Title: Interpreting hl7 segment hierarchy dynamically Jul. 19, 2022
-
Patent Title: Systems and methods for improved efficiency Mar. 10, 2020
-
Patent Title: Minimize garbage collection in hl7 manipulation Feb. 04, 2020
-
Patent Title: Interpreting hl7 segment hierarchy dynamically Nov. 05, 2019
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Recent insights relating to HCAT
Number of mentions of HCAT in WallStreetBets Daily Discussion
Recent picks made for HCAT stock on CNBC
ETFs with the largest estimated holdings in HCAT
|
Shareholder
|
Shares Held
|
|---|
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view HCAT Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.